SRZN.NASDAQSurrozen, Inc/de

Form 4: Surrozen COO Granted 500 Stock Options

Sentiment:

Insider Transaction Report


Surrozen, Inc.'s Chief Operating Officer, Charles O. Williams, was granted 500 employee stock options with an exercise price of $19.595.

Summary

  • Charles O. Williams, Chief Operating Officer of Surrozen, Inc. (SRZN), was granted 500 employee stock options.
  • The options have an exercise price of $19.595 per share.
  • The grant date for these options was January 23, 2026.
  • The options vest over a four-year period in 48 equal monthly installments, commencing from the grant date.
  • The expiration date for these options is January 22, 2036.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. A routine executive equity grant, which is generally a positive sign of management alignment, but does not provide new operational or financial news.

Positives

  • The grant of stock options to the Chief Operating Officer aligns management's interests with shareholder value.
  • The use of a Rule 10b5-1 plan indicates a pre-planned transaction, reducing concerns about opportunistic trading.

Risks

  • The value of the options is dependent on the future stock price of Surrozen, Inc. exceeding the exercise price of $19.595.
  • Vesting is subject to the reporting person's continued service, meaning unvested options could be forfeited if employment ceases.

Future Outlook

The filing itself does not provide a future outlook for the company, but rather reports an executive's equity transaction. The vesting schedule implies a long-term incentive for the COO.

Industry Context

This is a routine executive compensation event. Stock option grants are a common practice in the biotechnology/pharmaceutical industry to incentivize long-term performance and retain key talent.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages across various industries, including biotechnology. The specific number of options and exercise price would need to be compared against peer companies of similar size and stage to assess if it's within industry norms, but this filing alone does not provide enough context for a detailed comparison.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdherenceThe transaction was made pursuant to a Rule 10b5-1(c) plan, a corporate governance mechanism allowing insiders to pre-schedule stock trades to avoid concerns about insider trading.01/23/2026Enhances transparency and reduces potential for accusations of opportunistic trading by the executive.

Related Party Transactions

  • The grant of employee stock options to Charles O. Williams, an officer of Surrozen, Inc., constitutes a related party transaction as it involves a key management personnel and the company.

Stakeholder Impact

  • Shareholders: The grant of options aims to align management incentives with shareholder value creation, though potential future exercise could lead to minor dilution.
  • Employees: This is an executive compensation event, reflecting the company's strategy for incentivizing key personnel.

Next Steps

  • The options will vest monthly over the next four years, subject to Charles O. Williams' continued service.

Key Dates

DateDescription
01/23/2026Grant date of 500 employee stock options to Charles O. Williams.
01/26/2026Date the Form 4 was signed and filed.
01/22/2036Expiration date of the granted employee stock options.

Keywords

Surrozen, SRZN, Stock Options, Insider Trading, Form 4, Executive Compensation, Charles O. Williams, Chief Operating Officer, Equity Grant, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.